Anti-GALNT5 monoclonal antibody

Pre-made anti-GALNT5 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GALNT5/GALNT5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0885-Ab-1/ GM-Tg-hg-IP0885-Ab-2Anti-Human GALNT5 monoclonal antibodyHuman
GM-Tg-rg-IP0885-Ab-1/ GM-Tg-rg-IP0885-Ab-2Anti-Rat GALNT5 monoclonal antibodyRat
GM-Tg-mg-IP0885-Ab-1/ GM-Tg-mg-IP0885-Ab-2Anti-Mouse GALNT5 monoclonal antibodyMouse
GM-Tg-cynog-IP0885-Ab-1/ GM-Tg-cynog-IP0885-Ab-2Anti-Cynomolgus/ Rhesus macaque GALNT5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0885-Ab-1/ GM-Tg-felg-IP0885-Ab-2Anti-Feline GALNT5 monoclonal antibodyFeline
GM-Tg-cang-IP0885-Ab-1/ GM-Tg-cang-IP0885-Ab-2Anti-Canine GALNT5 monoclonal antibodyCanine
GM-Tg-bovg-IP0885-Ab-1/ GM-Tg-bovg-IP0885-Ab-2Anti-Bovine GALNT5 monoclonal antibodyBovine
GM-Tg-equg-IP0885-Ab-1/ GM-Tg-equg-IP0885-Ab-2Anti-Equine GALNT5 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0885-Ab-1/ GM-Tg-hg-IP0885-Ab-2; GM-Tg-rg-IP0885-Ab-1/ GM-Tg-rg-IP0885-Ab-2;
GM-Tg-mg-IP0885-Ab-1/ GM-Tg-mg-IP0885-Ab-2; GM-Tg-cynog-IP0885-Ab-1/ GM-Tg-cynog-IP0885-Ab-2;
GM-Tg-felg-IP0885-Ab-1/ GM-Tg-felg-IP0885-Ab-2; GM-Tg-cang-IP0885-Ab-1/ GM-Tg-cang-IP0885-Ab-2;
GM-Tg-bovg-IP0885-Ab-1/ GM-Tg-bovg-IP0885-Ab-2; GM-Tg-equg-IP0885-Ab-1/ GM-Tg-equg-IP0885-Ab-2
Products NameAnti-GALNT5 monoclonal antibody
Formatmab
Target NameGALNT5
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GALNT5 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0885-Ag-1Recombinant multi-species GALT5/ GALNT5/ GALNAC-T5 protein


    Target information

    Target IDGM-IP0885
    Target NameGALNT5
    Gene ID11227,241391,83627,697430,488359,101090539,504711,100050823
    Gene Symbol and Synonyms4832424J23,GALNAC-T5,GALNACT5,GALNT5
    Uniprot AccessionQ7Z7M9,O88422
    Uniprot Entry NameGALT5_HUMAN,GALT5_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000136542
    Target ClassificationN/A

    The target: GALNT5, gene name: GALNT5, also named as GALNAC-T5, GALNACT5. The protein encoded by this gene is a membrane-bound polypeptide N-acetylgalactosaminyltransferase that is found in the Golgi. The encoded protein catalyzes the first step in the mucin-type O-glycosylation of Golgi proteins, transfering an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. [provided by RefSeq, Aug 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.